📈

Trading Model Summary

Jul 4, 2025

Summary

  • The discussion focused on a specific trading model implemented this year, with a detailed walkthrough of recent market entries, exits, and risk management tactics around fair value gaps and "new week opening gaps."
  • The participant outlined their trade executions, stop loss management, and partial take-profit strategy, referencing specific chart levels and price action decisions.
  • No final decisions, team actions, or broader organizational topics were discussed.

Action Items

  • None specified.

Trading Model Execution & Walkthrough

  • The trading model is based on price action relative to fair value gaps (FVG) and the "new week opening gap," focusing on short trades when price is below key levels.
  • Partial profits were taken as price moved through the 10 a.m. low, with stops actively managed (lowered as price developed).
  • Additional buy and sell limit orders were placed as price returned to and reacted with the new week opening gap boundaries, with continued focus on downside expansion.
  • The trader emphasized letting the market work after stops were adjusted, checking in periodically rather than monitoring constantly.
  • Mentioned best-case downside target (20,640 level), but clarified this is a scenario, not a requirement.
  • Final partials taken as price made lower lows, with stops further reduced to minimize risk.
  • Noted missing some possible setups due to stepping away from the chart, and described the use of an alert for monitoring stop-outs.
  • The session ended with a reflection on significant volatility and wildcard price action for the day, with risk tolerance clearly defined (no additional trades once stopped out).

Decisions

  • No further trades after stop-out — Participant decided to halt trading for the session after reaching the defined stop-out point, citing risk management protocol and heightened market volatility.

Open Questions / Follow-Ups

  • None identified; the discussion was a solo walkthrough without open items requiring follow-up.